ghk cu pills vs injection FDA scientists flag concerns with peptides as RFK Jr. tries to ease access : NPR GHK-Cu: The Regenerative Peptide for

ERK1/2 & VEGFR2 Mechanism Musculoskeletal Scoping Review (PMC, 2025) A 2025 scoping review confirmed BPC-157 activates VEGFR2 and drives nitric oxide synthesis via the Akt-eNOS axis, promoting angiogenesis, fibroblast activity, and neuromuscular stabilisation

It accelerates cell renewal, reduces inflammation, and restores skin's smoothness and health

For patients losing significant weight on compounded semaglutide or tirzepatide, topical GHK-Cu is sometimes used to support skin elasticity, though specific evidence in this population is limited

The World Anti-Doping Agency (WADA), which regulates the drugs and other substances that elite athletes are allowed to take in and out of competition, banned the peptide in 2022 because BPC-157, according to its website, lacks current approval by any governmental regulatory health authority for human therapeutic use. But despite that regulatory action, trainers admit that they still work with elite and pro athletes who choose to take the peptide during downtime to speed recovery from injuries and surgerieswith relatively little fear of repercussions

That design makes it much harder for the body to break down, so it lasts longer than a normal peptide